CAMP
CAMP
NASDAQ · Biotechnology

Camp4 Therapeutics Corp

$3.84
+0.25 (+6.96%)
As of Feb 8, 2:05 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 368.79M 346.38M 334.67M
Net Income 5.96M 4.54M 4.70M
EPS
Profit Margin 1.6% 1.3% 1.4%
Rev Growth +17.9% -7.3% +7.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 81.61M 80.11M 79.74M
Total Equity 97.96M 93.68M 102.65M
D/E Ratio 0.83 0.86 0.78
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 7.81M 7.32M 6.13M
Free Cash Flow 4.41M 4.25M 6.96M